CaplanAI. Mesenchymal stem cells: time to change the name!Stem Cells Transl Med. 2017;6(6):1445-1451.
3.
ConnellDDatirAAlyasFCurtisM. Treatment of lateral epicondylitis using skin-derived tenocyte-like cells. Br J Sports Med. 2009;43(4):293-298.
4.
DominiciMLe BlancKMuellerI, et al. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.
5.
FangWHVangsnessCTJr. Food and Drug Administration's position on commonly injected biologic materials in orthopaedic surgery. Am J Sports Med. Published online March26, 2021. doi:10.1177/0363546521990900
6.
HorwitzEMLe BlancKDominiciM, et al; International Society for Cellular Therapy. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy. 2005;7(5):393-395.
MuschlerGFMiduraRNakamotoC. Practical modeling concepts for connective tissue stem cell and progenitor compartment kinetics. J Biomed Biotechnol. 2003;3:170-193.
10.
NolanJPDugganE. Analysis of individual extracellular vesicles by flow cytometry. Methods Mol Biol. 2018;1678:79-92.
11.
PaneroAJHiraharaAMAndersenWJRothenbergJFierroF. Are amniotic fluid products stem cell therapies? A study of amniotic fluid preparations for mesenchymal stem cells with bone marrow comparison. Am J Sports Med. 2019;47(5):1230-1235.
12.
RodeoSA. E-CEL UVEC cells as an adjunct cell therapy for the arthroscopic rotator cuff repair in adults. First posted August15, 2019. Last update postedApril1, 2021. https://clinicaltrials.gov/ct2/show/NCT04057833
13.
RuossSWalkerJTNasamranCA, et al. Strategies to identify mesenchymal stromal cells in minimally manipulated human bone marrow aspirate concentrate lack consensus. Am J Sports Med. 2021; 49(5):1313-1322.
